Signal2026-07-09
ClinicalTrials.gov

[PHASE3] A Phase III Trial of Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma

Part of

Molecular Profiling In Endocrine Neoplasms

Open primary sourceSee the whole picture